Covid vaccines: what are the implications of new variants of virus?

UK, South Africa and Brazil variants indicate changes may be needed

In common with others, the virus that causes Covid-19 mutates as it spreads. Most mutations have little or no effect, but some can change the behaviour of the virus. Mutations in a variant found in the UK in September has helped the virus spread more easily and potentially more dangerously. Further changes in variants that emerged in South Africa and Brazil may help the virus resist antibodies induced by vaccines and Covid infections from the first wave.

Why would the vaccines be updated?
If scientists spot new variants of coronavirus that are resistant to current vaccines then the vaccines will need to be redesigned to make them effective again. The more people who have immunity, either through vaccination or past infection, the more evolutionary pressure there is on the virus to evolve around that immunity. And when there’s lot of virus around, as there is now, there are more opportunities for resistant variants to emerge.

How are vaccines redesigned?
It depends on the vaccine. There are two vaccines being rolled out in the UK at the moment, one from Oxford/AstraZeneca, the other from Pfizer/BioNTech. Both contain genetic instructions for the spike protein which covers the surface of the virus. When the immune system encounters the spike protein it raises an army of antibody and T cells that is then primed to attack the virus should it come along. Updating the vaccine is not hard, at least conceptually: scientists simply replace the genetic code for the old spike protein with the code for the spike protein from the new variant.

How long does it take?
The vaccine can be redesigned on a computer within days. What takes more time is the manufacturing, testing and then large-scale production. Small batches of redesigned vaccine could be ready for testing within a month or two of the decision to update the formulation. Shots of the updated vaccine would then be tested in the laboratory to see whether they elicit the right immune response and do not raise any safety concerns. Regulators are in the process of deciding precisely what tests would be needed to make them confident an updated vaccine was safe and effective. It is highly unlikely they will require vaccines to go through a whole new round of clinical trials, just as seasonal flu shots are approved without such trials. As happened first time around, the updated vaccine could go into production while regulators pore over the safety and efficacy data, so that shots can be distributed as soon as the vaccine gets the green light. Though faster than updating flu vaccine, which is still grown in eggs, the whole process would still take months.

Would people need to be revaccinated?
Vaccinations programmes for Covid may need to mirror the annual flu vaccine programme, whereby the vaccine is modified each season to maximise its effectiveness. At the moment, the UK regulator believes there is no evidence that current vaccines will not work against the recently discovered new variants of coronavirus, but a strain known as 501Y.V2, which was first identified in South Africa, is causing concern because it is partially resistant to antibodies in people who caught Covid before. If surveillance shows that the variant, or others that emerge, are substantially resistant to current vaccines, then the vaccines will be updated. The new shots would then be given as soon as they are ready, with future updates happening annually or as-and-when new variants demand.


Ian Sample Science editor

The GuardianTramp

Related Content

Article image
Remdesivir has very little effect on Covid-19 mortality, WHO finds
Results of major trial described as sobering, with drug found not to improve survival rates

Sarah Boseley Health editor

16, Oct, 2020 @12:00 PM

Article image
Will Novavax and Johnson & Johnson Covid vaccines work against variants?
Everything you need to know about the trial results for the two new coronavirus vaccines

Archie Bland and Nicola Davis

29, Jan, 2021 @7:05 PM

Article image
UK study on mixing Covid vaccines between jabs to be expanded
Researchers to examine whether mixing vaccines may give longer-lasting immunity against virus

Sarah Marsh

14, Apr, 2021 @6:55 AM

Article image
Mixing Covid vaccines offers strong immune protection – study
Oxford researchers say having AstraZeneca then Pfizer jabs is almost as potent as two shots of Pfizer

Ian Sample and Natalie Grover

28, Jun, 2021 @5:38 PM

Article image
What are Covid variants – and should we be worried?
In the UK, all eyes are on South African, Brazilian and Kent variants - with mutations transmitting among the populationCoronavirus – latest updatesSee all our coronavirus coverage

Nicola Davis Science correspondent

05, Feb, 2021 @11:49 AM

Article image
T-cell Covid immunity 'present in adults six months after first infection'
Study suggests white blood cell levels higher in people who had symptoms

Natalie Grover

02, Nov, 2020 @2:41 PM

Article image
Brazilian Covid variant: what do we know about P1?
What threat does variant that is causing devastation in Brazil pose, and how is it different?

Sarah Boseley Health editor

08, Apr, 2021 @2:14 PM

Article image
Health experts criticise NHS advice to take ibuprofen for Covid-19
Comments come after French authorities say such drugs could aggravate condition

Hannah Devlin and Sarah Boseley

16, Mar, 2020 @2:48 PM

Article image
NHS urged to redistribute near-expiry vaccines as take-up slows in young
Doctors across England raise alarm as 170,000 Moderna doses at risk of expiry within fortnight

Jessica Elgot

01, Aug, 2021 @2:00 PM

Article image
UK pledges £29m more to fast-track vaccines against Covid variants
Money for Porton Down laboratory will help to ‘future-proof’ country, says Matt Hancock

Alexandra Topping

05, May, 2021 @8:57 AM